regulatory
confidence high
sentiment negative
materiality 0.60
Nutex Health Inc. (NUTX): Nasdaq/NYSE listing notice — Nutex Health receives second 180-day Nasdaq compliance period for bid price deficiency
Nutex Health Inc.
- Company failed to regain minimum $1 bid price by Nov 20, 2023 initial deadline.
- Nasdaq grants additional period until May 20, 2024 to cure the deficiency.
- Company may effect a reverse stock split if needed, no later than 10 business days before deadline.
- No immediate impact on common stock listing or trading at this time.
- Failure to cure by May 20, 2024 could lead to delisting and potential appeal to Nasdaq Hearings Panel.